Revelation Biosciences Statistics

Total Valuation

REVB has a market cap or net worth of $3.83 million. The enterprise value is -$9.52 million.

Market Cap	3.83M
Enterprise Value	-9.52M

Important Dates

The next estimated earnings date is Friday, August 7, 2026, before market open.

Earnings Date	Aug 7, 2026
Ex-Dividend Date	n/a

Share Statistics

REVB has 3.91 million shares outstanding. The number of shares has increased by 4,135.82% in one year.

Current Share Class	3.91M
Shares Outstanding	3.91M
Shares Change (YoY)	+4,135.82%
Shares Change (QoQ)	+110.48%
Owned by Insiders (%)	4.70%
Owned by Institutions (%)	4.52%
Float	3.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.29
P/TBV Ratio	0.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.02, with a Debt / Equity ratio of 0.06.

Current Ratio	10.02
Quick Ratio	9.96
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -124.41% and return on invested capital (ROIC) is -75.68%.

Return on Equity (ROE)	-124.41%
Return on Assets (ROA)	-66.19%
Return on Invested Capital (ROIC)	-75.68%
Return on Capital Employed (ROCE)	-73.88%
Weighted Average Cost of Capital (WACC)	3.09%
Revenue Per Employee	n/a
Profits Per Employee	-$2.39M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -90.27% in the last 52 weeks. The beta is -0.10, so REVB's price volatility has been lower than the market average.

Beta (5Y)	-0.10
52-Week Price Change	-90.27%
50-Day Moving Average	1.06
200-Day Moving Average	2.80
Relative Strength Index (RSI)	44.02
Average Volume (20 Days)	46,415

Short Selling Information

The latest short interest is 26,240, so 0.67% of the outstanding shares have been sold short.

Short Interest	26,240
Short Previous Month	34,510
Short % of Shares Out	0.67%
Short % of Float	0.76%
Short Ratio (days to cover)	0.45

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-10.07M
Pretax Income	-9.87M
Net Income	-21.50M
EBITDA	-10.04M
EBIT	-10.07M
Earnings Per Share (EPS)	-$15.33

Full Income Statement

Balance Sheet

The company has $14.11 million in cash and $759,044 in debt, giving a net cash position of $13.35 million or $3.42 per share.

Cash & Cash Equivalents	14.11M
Total Debt	759,044
Net Cash	13.35M
Net Cash Per Share	$3.42
Equity (Book Value)	12.99M
Book Value Per Share	3.32
Working Capital	12.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.69 million and capital expenditures -$71,879, giving a free cash flow of -$8.76 million.

Operating Cash Flow	-8.69M
Capital Expenditures	-71,879
Depreciation & Amortization	27,040
Net Borrowing	n/a
Free Cash Flow	-8.76M
FCF Per Share	-$2.24

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

REVB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4,135.82%
Shareholder Yield	-4,135.82%
Earnings Yield	-561.45%
FCF Yield	-228.76%

Analyst Forecast

The average price target for REVB is $19.25, which is 1,864.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.25
Price Target Difference	1,864.29%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Splits

The last stock split was on January 28, 2026. It was a reverse split with a ratio of 1:4.

Last Split Date	Jan 28, 2026
Split Type	Reverse
Split Ratio	1:4

Scores

Altman Z-Score	n/a
Piotroski F-Score	2